Experts say that “Ozempic blindness” fears may be overblown

GLP-1 drugs like Ozempic and Wegovy may slightly increase the risk of certain eye conditions and vision loss, but experts say that there's no reason to panic. According to two new studies published in the journal JAMA, patients with type 2 diabetes who take GLP-1s may face a modestly increased risk of diabetic retinopathy, but are still at decreased overall risk of life-threatening complications. The study authors recommended regular screening and monitoring to detect potential vision complications early.